Actively Recruiting
Real Life Study of Biologicals in Patients With Severe CRSwNP
Led by University Hospital, Ghent · Updated on 2024-04-15
180
Participants Needed
1
Research Sites
461 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a pragmatic, real-life, observational study recruiting adult patients with chronic rhinosinusitis with nasal polyposis who are eligible to start biologicals as standard treatment. The aim of this study is to observe the long-term outcomes of biologicals in CRSwNP patients with or without comorbid asthma in 'real life'. Moreover, the investigators will gain insight into the mechanisms of biologicals in the local and systemic immunity of these patients and investigate novel local and systemic biomarkers and predictors of response.
CONDITIONS
Official Title
Real Life Study of Biologicals in Patients With Severe CRSwNP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent form
- Age between 18 and 80 years
- Able to follow the study protocol
- Patients with severe allergic and/or eosinophilic asthma currently treated with or starting biological therapy
- Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) with or without asthma starting biological therapy and meeting reimbursement criteria
You will not qualify if you...
- Patients who do not meet the reimbursement criteria for biological therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ghent University Hospital
Ghent, Belgium, 9000
Actively Recruiting
Research Team
M
Manon Blauwblomme, Masters
CONTACT
P
Philippe Gevaert, Prof. Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here